drugset / Trial / NCT06237465

Botulinum Toxin-A for Hidradenitis Suppurativa

NCT06237465

Phase 4 Withdrawn Yale University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this research study is to determine if the medication Botulinum Toxin-A (BTX-A) is effective in treating hidradenitis suppurativa (HS)

Timeline

Start
2025-01
Primary completion
2025-06
Completion
2026-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 50 iu Other